Opexa Therapeutics
Opexa Therapeutics NASDAQ: OPXA, formerly known as PharmaFrontiers, is a U.S. biotechnology company that develops autologous cellular therapies for the treatment of multiple sclerosis, congestive heart failure, and diabetes. The company is focused on autologous cellular therapy applications based on its proprietary stem cell and T cell vaccination technologies.
History[edit]
Founded in 2003, the company was originally known as PharmaFrontiers Corp. In October 2004 PharmaFrontiers acquired the privately held company Opexa Pharmaceuticals Inc.[1] In June 2006 the company changed its name to Opexa Therapeutics, Inc.[2]
In 2009 the company sold its stem cell technology to Novartis and focused all of its attention on the continuing development of Tovaxin.[3]
Research areas and products[edit]
Key products and research include:
- Tcelna, previously known as Tovaxin:[4] A proposed T cell therapeutic vaccine for multiple sclerosis,[5] which was granted Fast Track status by the U.S. Food and Drug Administration. In January 2011 the FDA approved the product for Phase 3 clinical trials.[6]
- Heart: early development-stage stem cell therapy (currently in standby)
- Diabetes: early development-stage stem cell therapy (currently in standby)
Location[edit]
Opexa Therapeutics is located in The Woodlands, Texas 30 miles (48 km) north of Houston, Texas. The company has a 10,200 sq ft (950 m2) facility on 3 acres (12,000 m2) in The Woodlands.
References[edit]
- ↑ "PharmaFrontiers to acquire Opexa". Houston Business Journal. October 8, 2004. Retrieved 18 August 2012.
- ↑ "PharmaFrontiers becomes Opexa Therapeutics, executes stock split". Houston Business Journal. June 19, 2006. Retrieved 18 August 2012.
- ↑ "Opexa sells stem cell tech to Novartis; shares zoom". Reuters. August 7, 2009. Retrieved 18 August 2012.
- ↑ "Opexa Therapeutics Announces Tcelna(TM) as New Brand Name for MS Therapy". MarketWatch. Wall Street Journal. May 21, 2012. Retrieved 18 August 2012.
- ↑ "MS vaccine testing to start in US". BBC News. March 8, 2006. Retrieved 18 August 2012.
- ↑ "Opexa drug breakthrough gives firm big-league shot". Houston Business Journal. January 14, 2011. Retrieved 18 August 2012.
External links[edit]
This article "Opexa Therapeutics" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
